泪道装置市场规模、份额及成长分析（按产品、应用、最终用途及地区划分）－2026-2033年产业预测

预计到 2024 年，泪道装置市场规模将达到 1.7147 亿美元，到 2025 年将达到 1.7798 亿美元，到 2033 年将达到 2.3986 亿美元，预测期（2026-2033 年）的复合年增长率为 3.8%。

泪道器材市场正经历强劲成长，这主要得益于各年龄层对眼部疾病的认知和诊断水准的提高。眼科疾病发病率的上升推动了对泪小管栓塞、泪道支架和冲洗系统等先进解决方案的需求。技术进步和精细的手术技巧也在改善患者的治疗效果，进一步促进了市场扩张。人口老化和老龄化相关眼科疾病率的上升是推动该领域持续成长的主要因素。製造商和医疗服务提供者致力于创新研发，以满足泪道疾病患者不断变化的需求，同时专注于提升医疗品质和舒适度。监管政策和报销政策正在显着影响市场动态，为眼科器械行业的企业提供了广泛的发展机会。

泪道装置市场驱动因素

泪道系统设备市场的主要驱动力是全球眼科疾病率的上升。人口老化、生活方式的改变以及萤幕使用时间的增加是造成这一现象的原因，这些因素都会导致干眼症和各种泪道系统疾病等问题。随着人们对这些问题的认识不断提高，对用于辅助诊断和治疗这些疾病的泪道系统设备的需求也随之增长。这种日益增长的需求不仅促使人们更加关注创新解决方案，也显着推动了整个泪道系统设备市场的扩张。

泪道医疗设备市场的限制

泪道器材市场面临的主要挑战之一是严格的法规环境，这往往导致新产品和改良产品核准流程的延误。监管机构，尤其是在北美和欧洲，对医疗设备製定了严格的标准，从而延长了创新产品的上市时间。这种复杂的法规结构会阻碍创新步伐和整体市场成长，对现有企业和新参与企业都产生影响。这些限制会制约企业的发展机会，并限制其快速回应不断变化的患者需求和技术进步的能力。

泪道装置市场趋势

泪道器材市场正经历着向微创手术的显着转变，这反映出患者和医疗服务提供者越来越倾向于选择能够确保更短恢復时间和更高舒适度的治疗方案。这一趋势正在推动创新，并促使先进的微创泪道器材（包括微型内视镜和专用导管）的研发，以有效治疗泪道系统疾病。随着对最大限度减少术后併发症的手术方案的需求不断增长，製造商正在加强研发投入，以调整产品线，满足不断变化的患者照护需求。这正在塑造泪道器材市场的未来。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 专利分析

全球泪道设备市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 插管套装
• 支架和导管
• 套管和刮刀
• 扩充器

全球泪道装置市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 青光眼
• 干眼症
• 泪腺炎症
• 溢泪
• 其他的

全球泪道设备市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 医院
• 诊断中心
• 门诊护理中心 (ACC)

全球泪道装置市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• FCI Ophthalmics（France）
• Kaneka Corporation（Japan）
• Cook Group（USA）
• BVI（UK）
• Rumex International（USA）
• Bess Medical Technology GmbH（Germany）
• Bausch and Lomb Incorporated（USA）
• Braun Melsungen AG（Germany）
• OASIS Medical, Inc.（USA）
• Beaver-Visitec International（USA）
• FC Optics Ltd.（Israel）
• OptiMedica Corporation（USA）
• Diamatrix Ltd.（UK）
• FCI SAS（France）
• Novartis AG（Switzerland）
• Eye Kon Medical, Inc.（USA）

结论与建议

Lacrimal Devices Market size was valued at USD 171.47 Million in 2024 and is poised to grow from USD 177.98 Million in 2025 to USD 239.86 Million by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).

The lacrimal devices market is experiencing robust growth driven by heightened awareness and diagnosis of ophthalmic conditions across demographics. The rising incidence of eye disorders has spurred increased demand for advanced solutions, including punctal plugs, lacrimal stents, and irrigation systems. Technological advancements and refined surgical techniques have also enhanced patient outcomes, further fueling market expansion. The aging population, coupled with a rise in age-related eye conditions, ensures sustained growth in this sector. Manufacturers and healthcare providers are dedicated to innovative developments that cater to the evolving needs of patients suffering from lacrimal disorders, focusing on enhancing care quality and comfort. Regulatory influences and reimbursement policies significantly shape market dynamics, presenting promising opportunities for companies in the ophthalmic devices landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lacrimal Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lacrimal Devices Market Segments Analysis

Global Lacrimal Devices Market is segmented by Product, Application, End-use and region. Based on Product, the market is segmented into Intubation Sets, Stents and Tubes, Cannula and Spatula and Dilators. Based on Application, the market is segmented into Glaucoma, Dry Eye, Lacrimal Gland Inflammation, Epiphora and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Care Centers (ACC). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lacrimal Devices Market

The lacrimal devices market is primarily propelled by the rising prevalence of eye disorders on a global scale. Contributing factors include an aging population, lifestyle changes, and the surge in screen time, all of which lead to conditions such as dry eye syndrome and various lacrimal system disorders. As awareness of these issues grows, so does the demand for lacrimal devices designed to assist in the diagnosis and treatment of these conditions. This heightened need not only enhances the focus on innovative solutions but also significantly fuels the overall expansion of the lacrimal devices market.

Restraints in the Lacrimal Devices Market

A significant challenge facing the lacrimal devices market is the rigorous regulatory environment, which often results in delays when seeking approvals for new products or modifications. Regulatory bodies, especially in North America and Europe, impose strict standards for medical devices, leading to prolonged timelines for bringing innovations to market. This complex regulatory framework can hinder both the pace of innovation and the overall growth of the market, affecting established companies as well as new market entrants. Such constraints can restrict opportunities for advancement and limit the ability to respond swiftly to evolving patient needs and technological advancements.

Market Trends of the Lacrimal Devices Market

The lacrimal devices market is experiencing a pronounced shift towards minimally invasive procedures, reflecting a growing preference among patients and healthcare providers for options that ensure quicker recovery times and enhanced comfort. This trend is catalyzing innovation, leading to the development of advanced minimally invasive lacrimal devices, including microendoscopes and specialized catheters designed to effectively treat lacrimal system disorders. As the demand for procedures that minimize postoperative complications continues to rise, manufacturers are increasingly investing in research and development to align product offerings with these evolving patient care preferences, thereby shaping the future landscape of the lacrimal devices market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Lacrimal Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Intubation Sets
• Stents and Tubes
• Cannula and Spatula
• Dilators

Global Lacrimal Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Glaucoma
• Dry Eye
• Lacrimal Gland Inflammation
• Epiphora
• Others

Global Lacrimal Devices Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Ambulatory Care Centers (ACC)

Global Lacrimal Devices Market Size & CAGR (2026-2033)

• North America (Product, Application, End-use)
  • US
  • Canada
• Europe (Product, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• FCI Ophthalmics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BVI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rumex International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bess Medical Technology GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch and Lomb Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OASIS Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beaver-Visitec International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FC Optics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMedica Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamatrix Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FCI S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Kon Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations